Título: Metoprolol in Critically Ill Patients With COVID-19

Autor: Agustín Clemente-Moragón, Juan Martínez-Milla, Eduardo Oliver, Arnoldo Santos, Javier Flandes, Iker Fernández, Lorena Rodríguez-González, Cristina Serrano del Castillo, Ana-María Ioan,  María López-Álvarez, Sandra Gómez Talavera, Carlos Galán-Arriola, Valentín Fuster, César Pérez-Calvo, Borja Ibáñez

Publicación: Journal of the American College of Cardiology

Fecha de publicación: 2021

Resumen: Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting